Advancing psychosocial care in cancer patients

Luigi Grassi, David Spiegel, Michelle Riba, Luigi Grassi, David Spiegel, Michelle Riba

Abstract

Cancer is a devastating disease causing significant psychological problems among patients and their families. In the past few decades, there have been growing implementation and dissemination of screening methods for the psychological consequences of cancer, including distress, depression, anxiety, post-traumatic stress, and demoralisation. Also, guidelines for the management of psychological distress have been developed and endorsed by a number of scientific cancer associations. This review examines some of the most significant related issues, also focusing on recent advances in psychosocial and psychopharmacological interventions as a part of a mandatory, integrated, and comprehensive approach to cancer care.

Keywords: cancer; distress; psycho-oncology; psychological screening assessment; psychopathology; psychotherapy.

Conflict of interest statement

No competing interests were disclosed.No competing interests were disclosed.No competing interests were disclosed.No competing interests were disclosed.

References

    1. World Health Organization: Cancer.WHO, Geneva,2017.
    1. Grassi L, Biancosino B, Marmai L, et al. : Psychological factors affecting oncology conditions. Adv Psychosom Med. 2007;28:57–71. 10.1159/000106797
    1. Caruso R, Nanni MG, Riba MB, et al. : The burden of psychosocial morbidity related to cancer: patient and family issues. Int Rev Psychiatry. 2017;29(5):389–402. 10.1080/09540261.2017.1288090
    1. Nipp RD, El-Jawahri A, Fishbein JN, et al. : The relationship between coping strategies, quality of life, and mood in patients with incurable cancer. Cancer. 2016;122(13):2110–6. 10.1002/cncr.30025
    2. F1000 Recommendation

    1. McFarland DC, Holland JC: The management of psychological issues in oncology. Clin Adv Hematol Oncol. 2016;14(12):999–1009.
    2. F1000 Recommendation

    1. Bultz BD, Carlson LE: Emotional distress: the sixth vital sign--future directions in cancer care. Psychooncology. 2006;15(2):93–5. 10.1002/pon.1022
    1. Bultz BD, Johansen C: Screening for distress, the 6th vital sign: where are we, and where are we going? Psychooncology. 2011;20(6):569–71. 10.1002/pon.1986
    1. Travado L, Breitbart W, Grassi L, et al. : 2015 President's Plenary International Psycho-oncology Society: psychosocial care as a human rights issue-challenges and opportunities. Psychooncology. 2017;26(4):563–9. 10.1002/pon.4209
    1. National Comprehensive Cancer Network (NCCN): Distress management.Version 2.2017. NCCN,2017.
    1. Mitchell AJ, Chan M, Bhatti H, et al. : Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol. 2011;12(2):160–74. 10.1016/S1470-2045(11)70002-X
    1. Cordova MJ, Riba MB, Spiegel D: Post-traumatic stress disorder and cancer. Lancet Psychiatry. 2017;4(4):330–8. 10.1016/S2215-0366(17)30014-7
    1. Caruso R, Nanni MG, Riba M, et al. : Depressive spectrum disorders in cancer: prevalence, risk factors and screening for depression: a critical review. Acta Oncol. 2017;56(2):146–55. 10.1080/0284186X.2016.1266090
    1. Caruso R, GiuliaNanni M, Riba MB, et al. : Depressive Spectrum Disorders in Cancer: Diagnostic Issues and Intervention. A Critical Review. Curr Psychiatry Rep. 2017;19(6):33. 10.1007/s11920-017-0785-7
    1. Spiegel D, Riba MB: Managing anxiety and depression during treatment. Breast J. 2015;21(1):97–103. 10.1111/tbj.12355
    1. Roth AJ, Carter J, Seidel B, et al. : Sexual Problems After : Holland JC, Breitbart WS, Jacobsen PB, Loscalzo MJ, McCorkle R, Butow PN, editors. Psycho-Oncology: Oxford University Press;2015;220–224. 10.1093/med/9780199363315.003.0028
    1. Tang PL, Wang HH, Chou FH: A Systematic Review and Meta-Analysis of Demoralization and Depression in Patients With Cancer. Psychosomatics. 2015;56(6):634–43. 10.1016/j.psym.2015.06.005
    2. F1000 Recommendation

    1. Robinson S, Kissane DW, Brooker J, et al. : A systematic review of the demoralization syndrome in individuals with progressive disease and cancer: a decade of research. J Pain Symptom Manage. 2015;49(3):595–610. 10.1016/j.jpainsymman.2014.07.008
    2. F1000 Recommendation

    1. Grassi L, Nanni MG: Demoralization syndrome: New insights in psychosocial cancer care. Cancer. 2016;122(14):2130–3. 10.1002/cncr.30022
    1. Grassi L, Caruso R, Nanni MG: Somatization and somatic symptom presentation in cancer: a neglected area. Int Rev Psychiatry. 2013;25(1):41–51. 10.3109/09540261.2012.731384
    1. Forsythe LP, Kent EE, Weaver KE, et al. : Receipt of psychosocial care among cancer survivors in the United States. J Clin Oncol. 2013;31(16):1961–9. 10.1200/JCO.2012.46.2101
    1. Sarkar S, Sautier L, Schilling G, et al. : Anxiety and fear of cancer recurrence and its association with supportive care needs and health-care service utilization in cancer patients. J Cancer Surviv. 2015;9(4):567–75. 10.1007/s11764-015-0434-2
    2. F1000 Recommendation

    1. Vehling S, Mehnert A, Hartmann M, et al. : Anxiety and depression in long-term testicular germ cell tumor survivors. Gen Hosp Psychiatry. 2016;38:21–5. 10.1016/j.genhosppsych.2015.09.001
    2. F1000 Recommendation

    1. Stanton AL, Rowland JH, Ganz PA: Life after diagnosis and treatment of cancer in adulthood: contributions from psychosocial oncology research. Am Psychol. 2015;70(2):159–74. 10.1037/a0037875
    2. F1000 Recommendation

    1. Stanton AL: What happens now? Psychosocial care for cancer survivors after medical treatment completion. J Clin Oncol. 2012;30(11):1215–20. 10.1200/JCO.2011.39.7406
    1. Barnett M, McDonnell G, DeRosa A, et al. : Psychosocial outcomes and interventions among cancer survivors diagnosed during adolescence and young adulthood (AYA): a systematic review. J Cancer Surviv. 2016;10(5):814–31. 10.1007/s11764-016-0527-6
    2. F1000 Recommendation

    1. Aaronson NK, Mattioli V, Minton O, et al. : Beyond treatment - Psychosocial and behavioural issues in cancer survivorship research and practice. EJC Suppl. 2014;12(1):54–64. 10.1016/j.ejcsup.2014.03.005
    1. Giese-Davis J, Collie K, Rancourt KM, et al. : Decrease in depression symptoms is associated with longer survival in patients with metastatic breast cancer: a secondary analysis. J Clin Oncol. 2011;29(4):413–20. 10.1200/JCO.2010.28.4455
    1. Anguiano L, Mayer DK, Piven ML, et al. : A literature review of suicide in cancer patients. Cancer Nurs. 2012;35(4):E14–26. 10.1097/NCC.0b013e31822fc76c
    1. Kissane DW: Unrecognised and untreated depression in cancer care. Lancet Psychiatry. 2014;1(5):320–1. 10.1016/S2215-0366(14)70345-1
    1. Donovan KA, Grassi L, McGinty HL, et al. : Validation of the distress thermometer worldwide: state of the science. Psychooncology. 2014;23(3):241–50. 10.1002/pon.3430
    1. Mitchell AJ: Short screening tools for cancer-related distress: a review and diagnostic validity meta-analysis. J Natl Compr Canc Netw. 2010;8(4):487–94. 10.6004/jnccn.2010.0035
    1. Mitchell AJ: Pooled results from 38 analyses of the accuracy of distress thermometer and other ultra-short methods of detecting cancer-related mood disorders. J Clin Oncol. 2007;25(29):4670–81. 10.1200/JCO.2006.10.0438
    1. Vodermaier A, Linden W, Siu C: Screening for emotional distress in cancer patients: a systematic review of assessment instruments. J Natl Cancer Inst. 2009;101(21):1464–88. 10.1093/jnci/djp336
    1. Mitchell AJ, Meader N, Davies E, et al. : Meta-analysis of screening and case finding tools for depression in cancer: evidence based recommendations for clinical practice on behalf of the Depression in Cancer Care consensus group. J Affect Disord. 2012;140(2):149–60. 10.1016/j.jad.2011.12.043
    1. Hartung TJ, Friedrich M, Johansen C, et al. : The Hospital Anxiety and Depression Scale (HADS) and the 9-item Patient Health Questionnaire (PHQ-9) as screening instruments for depression in patients with cancer. Cancer. 2017;123(21):4236–4243. 10.1002/cncr.30846
    1. Grassi L, Sabato S, Rossi E, et al. : Use of the diagnostic criteria for psychosomatic research in oncology. Psychother Psychosom. 2005;74(2):100–7. 10.1159/000083168
    1. National Comprehensive Cancer Network: NCCN Clinical Practice Guidelines in Oncology.Distress Management. Version 2. © National Comprehensive Cancer Network, Fort Washington, PA USA.2016.
    1. Howell D, Keshavarz H, Esplen MJ, et al. : A Pan Canadian Practice Guideline: Screening, Assessment and Care of Psychosocial Distress, Depression, and Anxiety in Adults with Cancer.Toronto: Canadian Partnership Against Cancer and the Canadian Association of Psychosocial Oncology,2015.
    1. Howell D, Currie S, Mayo S, et al. : A Pan-Canadian Clinical Practice Guideline: Assessment of Psychosocial Health Care Needs of the Adult Cancer Patient. Toronto: Canadian Partnership Against Cancer (Cancer Journey Action Group) and the Canadian Association of Psychosocial Oncology,2009.
    1. Howell D , Hack TF, Oliver TK, et al. : A Pan-Canadian Practice Guideline Pan-Canadian Guidance on Organization and Structure of Survivorship Services and Psychosocial-Supportive Care Best Practices for Adult Cancer Survivors. Toronto: Canadian Partnership Against Cancer (Cancer Journey Action Group) and the Canadian Association of Psychosocial Oncology,2011.
    1. Wagner LI, Spiegel D, Pearman T: Using the science of psychosocial care to implement the new american college of surgeons commission on cancer distress screening standard. J Natl Compr Canc Netw. 2013;11(2):214–21. 10.6004/jnccn.2013.0028
    1. Andersen BL, DeRubeis RJ, Berman BS, et al. : Screening, assessment, and care of anxiety and depressive symptoms in adults with cancer: an American Society of Clinical Oncology guideline adaptation. J Clin Oncol. 2014;32(15):1605–19. 10.1200/JCO.2013.52.4611
    1. Pirl WF, Fann JR, Greer JA, et al. : Recommendations for the implementation of distress screening programs in cancer centers: report from the American Psychosocial Oncology Society (APOS), Association of Oncology Social Work (AOSW), and Oncology Nursing Society (ONS) joint task force. Cancer. 2014;120(19):2946–54. 10.1002/cncr.28750
    1. Clark PG, Bolte S, Buzaglo J, et al. : From distress guidelines to developing models of psychosocial care: current best practices. J Psychosoc Oncol. 2012;30(6):694–714. 10.1080/07347332.2012.721488
    1. Shaw JM, Price MA, Clayton JM, et al. : Developing a clinical pathway for the identification and management of anxiety and depression in adult cancer patients: an online Delphi consensus process. Support Care Cancer. 2016;24(1):33–41. 10.1007/s00520-015-2742-5
    2. F1000 Recommendation

    1. Carlson LE, Waller A, Mitchell AJ: Screening for distress and unmet needs in patients with cancer: review and recommendations. J Clin Oncol. 2012;30(11):1160–77. 10.1200/JCO.2011.39.5509
    1. Howell D, Hack TF, Green E, et al. : Cancer distress screening data: translating knowledge into clinical action for a quality response. Palliat Support Care. 2014;12(1):39–51. 10.1017/S1478951513000382
    1. Lazenby M, Tan H, Pasacreta N, et al. : The five steps of comprehensive psychosocial distress screening. Curr Oncol Rep. 2015;17(5):447. 10.1007/s11912-015-0447-z
    2. F1000 Recommendation

    1. Bickel KE, McNiff K, Buss MK, et al. : Defining High-Quality Palliative Care in Oncology Practice: An American Society of Clinical Oncology/American Academy of Hospice and Palliative Medicine Guidance Statement. J Oncol Pract. 2016;12(9):e828–38. 10.1200/JOP.2016.010686
    2. F1000 Recommendation

    1. Grassi L, Fujisawa D, Odyio P, et al. : Disparities in psychosocial cancer care: a report from the International Federation of Psycho-oncology Societies. Psychooncology. 2016;25(10):1127–36. 10.1002/pon.4228
    1. Tamagawa R, Garland S, Vaska M, et al. : Who benefits from psychosocial interventions in oncology? A systematic review of psychological moderators of treatment outcome. J Behav Med. 2012;35(6):658–73. 10.1007/s10865-012-9398-0
    1. Grassi L, Caruso R, Nanni MG: Psycho-oncology and optimal standards of cancer care: developments, multidisciplinary team approach and international Wise TN, Biondi M, Costantini A. (Eds.), Psycho-Oncology American Psychiatric Publishing Press, Arlington, VA,2013;315–339.
    1. Zainal NZ, Booth S, Huppert FA: The efficacy of mindfulness-based stress reduction on mental health of breast cancer patients: a meta-analysis. Psychooncology. 2013;22(7):1457–65. 10.1002/pon.3171
    1. Johannsen M, Farver I, Beck N, et al. : The efficacy of psychosocial intervention for pain in breast cancer patients and survivors: a systematic review and meta-analysis. Breast Cancer Res Treat. 2013;138(3):675–90. 10.1007/s10549-013-2503-4
    1. Hunter EG, Gibson RW, Arbesman M, et al. : Systematic Review of Occupational Therapy and Adult Cancer Rehabilitation: Part 1. Impact of Physical Activity and Symptom Management Interventions. Am J Occup Ther. 2017;71(2):7102100030p1–7102100030p11. 10.5014/ajot.2017.023564
    2. F1000 Recommendation

    1. Hunter EG, Gibson RW, Arbesman M, et al. : Systematic Review of Occupational Therapy and Adult Cancer Rehabilitation: Part 2. Impact of Multidisciplinary Rehabilitation and Psychosocial, Sexuality, and Return-to-Work Interventions. Am J Occup Ther. 2017;71(2):7102100040p1–7102100040p8. 10.5014/ajot.2017.023572
    2. F1000 Recommendation

    1. Barrera I, Spiegel D: Review of psychotherapeutic interventions on depression in cancer patients and their impact on disease progression. Int Rev Psychiatry. 2014;26(1):31–43. 10.3109/09540261.2013.864259
    1. Spiegel D: Mind matters in cancer survival. Psychooncology. 2012;21(6):588–93. 10.1002/pon.3067
    1. Galway K, Black A, Cantwell M, et al. : Psychosocial interventions to improve quality of life and emotional wellbeing for recently diagnosed cancer patients. Cochrane Database Syst Rev. 2012;11:CD007064. 10.1002/14651858.CD007064.pub2
    1. Classen CC, Kraemer HC, Blasey C, et al. : Supportive-expressive group therapy for primary breast cancer patients: a randomized prospective multicenter trial. Psychooncology. 2008;17(5):438–47. 10.1002/pon.1280
    1. Johnson JA, Rash JA, Campbell TS, et al. : A systematic review and meta-analysis of randomized controlled trials of cognitive behavior therapy for insomnia (CBT-I) in cancer survivors. Sleep Med Rev. 2016;27:20–8. 10.1016/j.smrv.2015.07.001
    2. F1000 Recommendation

    1. Kissane DW, Bloch S, Smith GC, et al. : Cognitive-existential group psychotherapy for women with primary breast cancer: a randomised controlled trial. Psychooncology. 2003;12(6):532–46. 10.1002/pon.683
    1. Breitbart W, Rosenfeld B, Pessin H, et al. : Meaning-centered group psychotherapy: an effective intervention for improving psychological well-being in patients with advanced cancer. J Clin Oncol. 2015;33(7):749–54. 10.1200/JCO.2014.57.2198
    2. F1000 Recommendation

    1. van der Spek N, Vos J, van Uden-Kraan CF, et al. : Efficacy of meaning-centered group psychotherapy for cancer survivors: a randomized controlled trial. Psychol Med. 2017;47(11):1990–2001. 10.1017/S0033291717000447
    2. F1000 Recommendation

    1. Rouleau CR, Garland SN, Carlson LE: The impact of mindfulness-based interventions on symptom burden, positive psychological outcomes, and biomarkers in cancer patients. Cancer Manag Res. 2015;7:121–31. 10.2147/CMAR.S64165
    2. F1000 Recommendation

    1. Carlson LE: Mindfulness-based interventions for coping with cancer. Ann N Y Acad Sci. 2016;1373(1):5–12. 10.1111/nyas.13029
    2. F1000 Recommendation

    1. Piet J, Würtzen H, Zachariae R: The effect of mindfulness-based therapy on symptoms of anxiety and depression in adult cancer patients and survivors: a systematic review and meta-analysis. J Consult Clin Psychol. 2012;80(6):1007–20. 10.1037/a0028329
    1. LeMay K, Wilson KG: Treatment of existential distress in life threatening illness: a review of manualized interventions. Clin Psychol Rev. 2008;28(3):472–93. 10.1016/j.cpr.2007.07.013
    1. Watson M, Kissane DW: Handbook of Psychotherapy in Cancer Care.Chichester, UK: John Wiley & Sons, Ltd;2011.
    1. Okuyama T, Akechi T, Mackenzie L, et al. : Psychotherapy for depression among advanced, incurable cancer patients: A systematic review and meta-analysis. Cancer Treat Rev. 2017;56:16–27. 10.1016/j.ctrv.2017.03.012
    2. F1000 Recommendation

    1. Greenlee H, DuPont-Reyes MJ, Balneaves LG, et al. : Clinical practice guidelines on the evidence-based use of integrative therapies during and after breast cancer treatment. CA Cancer J Clin. 2017;67(3):194–232. 10.3322/caac.21397
    2. F1000 Recommendation

    1. Caruso R, Grassi L, Nanni MG, et al. : Psychopharmacology in psycho-oncology. Curr Psychiatry Rep. 2013;15(9):393. 10.1007/s11920-013-0393-0
    1. Grassi L, Caruso R, Hammelef K, et al. : Efficacy and safety of pharmacotherapy in cancer-related psychiatric disorders across the trajectory of cancer care: a review. Int Rev Psychiatry. 2014;26(1):44–62. 10.3109/09540261.2013.842542
    1. Grassi L, Caruso R, Rodin G, et al. : The use of antidepressants in cancer care: a review and practical cila tips for oncologists. Annals of Oncology. (in press).
    1. Grassi L, Riba M, (Eds.): Psychopharmacology in oncology and palliative care.Springer, Berlin/New York,2014. 10.1007/978-3-642-40134-3
    1. Bultz BD, Cummings GG, Grassi L, et al. : 2013 President's Plenary International Psycho-oncology Society: embracing the IPOS standards as a means of enhancing comprehensive cancer care. Psychooncology. 2014;23(9):1073–8. 10.1002/pon.3618
    1. Li M, Fitzgerald P, Rodin G: Evidence-based treatment of depression in patients with cancer. J Clin Oncol. 2012;30(11):1187–96. 10.1200/JCO.2011.39.7372
    1. Traeger L, Greer JA, Fernandez-Robles C, et al. : Evidence-based treatment of anxiety in patients with cancer. J Clin Oncol. 2012;30(11):1197–205. 10.1200/JCO.2011.39.5632
    1. Andersen BL, Dorfman CS: Evidence-based psychosocial treatment in the community: considerations for dissemination and implementation. Psychooncology. 2016;25(5):482–90. 10.1002/pon.3864
    2. F1000 Recommendation

    1. Rubin G, Berendsen A, Crawford SM, et al. : The expanding role of primary care in cancer control. Lancet Oncol. 2015;16(12):1231–72. 10.1016/S1470-2045(15)00205-3

Source: PubMed

3
Abonnieren